Ranbaxy

  • News 360: Huge turnout on first poll phase in Assam, Tripura 07-04-2014 08:15 PM

    An estimated 72 per cent of the 64.4 lakh voters exercised their franchise peacefully in five Lok Sabha constituencies in Assam sealing the electoral fate of 51 contestants, including two union ministers in the first phase. ...
  • Sun Pharma to buy Ranbaxy in $3.2 billion deal 07-04-2014 08:31 AM

    Tokyo: Sun Pharmaceutical Industries Ltd said it will buy generic drug maker Ranbaxy Laboratories Ltd, which has hit regulatory snags in its key US market over quality issues, in an all-share deal with total equity value of $3.2 billion. Ranbaxy, India's No.1 drugmaker by sales and 63.4 per cent held...
  • SC notice to Centre, Ranbaxy on plea against adulterated drugs 14-03-2014 02:51 PM

    New Delhi: There is more trouble for pharma giant Ranbaxy. The Supreme Court has issued a notice to the company as well as the Centre on the basis of a petition that has sought a probe against Ranbaxy for allegedly supplying adulterated drugs in the country. The apex court has,...
  • Ranbaxy suspends drug ingredients shipment from 2 plants 25-02-2014 09:51 AM

    Tokyo: Drugmaker Ranbaxy Laboratories Ltd on Tuesday said it has suspended all shipments of pharmaceutical ingredients produced at two local factories to review processes and controls. The Toansa and Dewas plants are currently banned from shipping products to the United States following quality concerns, so the suspension will hit supplies...
  • US 'not targeting' India companies: FDA 22-02-2014 12:27 PM

    The United States is "not targeting" Indian companies, but has a strict quality control regime for all products being imported into America, the head of the US Food and Drug Administration said on Saturday. "We are not targeting Indian companies. We are undertaking our required regulatory activities. We inspect and...
  • FDA prohibits Ranbaxy products in US 24-01-2014 12:38 PM

    In a setback to Indian pharmaceutical giant Ranbaxy, the US has prohibited it from producing and distributing "substandard quality" drugs for the American market from its Toansa facility in Punjab. In an order, the Food and Drug Administration on Thursday prohibited Ranbaxy from distributing in the US the drugs manufactured...
  • USFDA bans drugs from Ranbaxy's Toansa API plant 24-01-2014 10:40 AM

    The US Food and Drug Administration (USFDA) has banned Ranbaxy's Punjab-based Toansa Active Pharmaceutical Ingredients (API) plant. "Ranbaxy Laboratories is prohibited from manufacturing and distributing active pharmaceutical ingredients (APIs) from its facility in Toansa, India, for FDA-regulated drug products. The Toansa facility is now subject to certain terms of a...
  • Suspected hair in a Ranbaxy tablet led to US import alert 18-09-2013 04:56 PM

    During a visit to a facility of leading drugmaker Ranbaxy Laboratories Ltd last year, US inspectors found that a black fibre embedded in a tablet may have been a hair from an employee's arm, according to documents seen by Reuters. That and other quality concerns led the US Food and...
  • US FDA bans imports from Ranbaxy's Mohali plant 16-09-2013 06:40 PM

    Mumbai: The US Food and Drug Administration has issued an import alert against drugs manufactured at Ranbaxy's Mohali plant in Punjab over quality concerns. This means Ranbaxy will not be able to ship drugs manufactured at the plant to the US until the ban is lifted. This is the third...
  • Adulterated drugs: Evidence against Ranbaxy likely to be furnished in SC 12-08-2013 09:00 AM

    New Delhi: Evidence in a case against Ranbaxy is likely to be furnished in the Supreme Court on Monday. Earlier in August, the Supreme Court while replying to a petition seeking cancellation of Ranbaxy's manufacturing licence had said that the petitioner can file the documents to prove that the company...
  • 9 pharmaceutical companies fined Rs 2500 cr for overcharging 19-07-2013 05:08 PM

    New Delhi: Nine pharmaceutical companies have been fined Rs 2500 crore by the National Pharmaceutical Pricing Authority (NPPA) for overcharging customers. The NPPA imposed penalty after the drug makers, which also include Ranbaxy, Dr. Reddy's Lab, Glenmark, Cipla and Cadilla, were overcharging patients on Doxofylline. The asthma drug was being...
  • Adulterated drugs: SC dismisses PIL against Ranbaxy 25-06-2013 11:35 AM

    New Delhi: The Supreme court on Tuesday dismissed a PIL against Ranbaxy. The court in its order said that there is no evidence to show that the pharma giant manufactured substandard drugs. The apex court also said that the petitioner failed to bring in evidence against Ranbaxy. The PIL was...
  • EU fines Ranbaxy, others for blocking cheaper drugs 19-06-2013 08:22 PM

    Brussels: European antitrust regulators fined nine drug makers, including Denmark's Lundbeck and India's Ranbaxy, a total of 146 million euros for blocking the supply of a cheaper anti-depressant to the market, the first EU sanction against such deals. The punishments follow a 2009 report by the European Commission on the...
  • Ranbaxy should improve on compliance: Vikas Dandekar 11-06-2013 04:57 PM

    The Supreme Court will hear a PIL on Tuesday seeking a ban on Ranbaxy drugs. The petitioner cited the pharma giant's case in the US where Ranbaxy USA admitted to selling substandard and adulterated drugs. The pharma giant has been asked to pay a fine of 500 million dollars. Ranbaxy...
  • SC to hear PIL seeking a ban on Ranbaxy drugs today 11-06-2013 08:49 AM

    New Delhi: The Supreme Court will hear a PIL on Tuesday seeking a ban on Ranbaxy drugs. The petitioner cited the pharma giant's case in the US - where Ranbaxy USA admitted to selling substandard and adulterated drugs. The pharma giant was asked to pay a fine of 500 million...
  • Apollo Pharmacy resumes selling Ranbaxy drugs 10-06-2013 01:06 PM

    Mumbai: Apollo Pharmacy started selling Ranbaxy drugs at its stores again on Monday after the company recertified its stocks. Apollo Pharmacy had on Friday issued a cautionary advisory against Ranbaxy drugs and had temporarily suspended their sale. Earlier, Mumbai's Jaslok Hospital had also stopped the use of Ranbaxy drugs. "Our...
  • Hospitals, chemists to wait for regulatory word on Ranbaxy 09-06-2013 12:51 PM

    New Delhi: Drug regulator DGCI is conducting a "focussed scrutiny" of medicines sold by Ranbaxy and some other drugmakers, but says it remains confident of the quality standards of Indian medicines despite concerns raised by US authorities over some of Ranbaxy's products. While the company continues to assert that its...
  • Apollo Pharmacy issues advisory against Ranbaxy drugs 07-06-2013 04:57 PM

    Mumbai: Apollo Pharmacy on Friday issued a cautionary advisory against Ranbaxy drugs and temporarily suspended their sale. Earlier, Mumbai's Jaslok Hospital had stopped the use of Ranbaxy drugs. "Our medical committee, which is a very strong committee within Apollo, has reviewed the matter and recommended, as a cautionary measure, we...
  • Ranbaxy CEO says the pharma company's medicines have always been safe 06-06-2013 08:10 AM

    Under attack for manufacturing spurious drugs, Ranbaxy CEO Arun Sawhney told CNN-IBN that Ranbaxy medicines are completely safe and that his company has resumed supplying medicines to Jaslok Hospital in Mumbai. ...
  • India @ 9 with Rajdeep Sardesai 05-06-2013 11:47 PM

    Gujarat Chief Minister Narendra Modi on Wednesday dared the government to arrest him in the Ishrat Jahan fake encounter case, according to sources. Sources say that Modi indirectly warned the government not to misuse the CBI. ...
  • News 360: Modi opposes NCTC, accusing Centre of playing big brother 05-06-2013 10:31 PM

    While Gujarat Chief Minister Narendra Modi opposes the proposed NCTC, accusing the Centre of playing big brother, the government launches its counter attack saying Modi wants to bring back POTA and TADA back. ...
  • Ranbaxy drugs are 'safe and efficacious': S African regulator 05-06-2013 07:15 PM

    Johannesburg: Generic drugs distributed in South Africa by Indian pharmaceutical giant Ranbaxy are "safe" and "efficacious", the country's regulator body said today, days after the beleaguered drug maker paid a fine of USD 500 million in the US for selling adulterated drugs there. "We are confident that drugs currently on...
  • Adulterated drugs: Mumbai hospital stops Ranbaxy products 05-06-2013 07:05 PM

    Mumbai: In more trouble for pharma giant Ranbaxy, one of Mumbai's top hospitals asked its consultants to stop buying its products over the adulterated drugs controversy. Mumbai's Jaslok hospital asked its consultants to stop prescribing Ranbaxy products on Wednesday after the company agreed to pay $ 500 million in settlement...
  • Ranbaxy case: Should Indian patients worry over sub-standard drugs? 05-06-2013 02:26 PM

    Mumbai: India exports drugs worth more than 15 billion dollars every year, a majority of which are US-bound. Questions are being raised about the standards and quality, after Ranbaxy's whopping 500 million dollar settlement with the US government. The generic drugs in question were manufactured at Ranbaxy's plants in Paonta...
  • PIL in SC against Ranbaxy for manufacturing adulterated drugs 05-06-2013 09:22 AM

    New Delhi: A Public-interest litigation (PIL) has been moved in the Supreme Court against Ranbaxy Pharma. The PIL is seeking prosecution of all Ranbaxy directors and sealing of its manufacturing units at Paonta Sahib and Devas. This was based on Ranbaxy USA's 500 million dollar settlement with the US for...
  • EU to fine Ranbaxy, others for blocking generic drugs 04-06-2013 10:14 AM

    Brussels: A European regulator will fine Denmark's Lundbeck, India's Ranbaxy and seven other makers of generic drugs for limiting the supply of cheaper medicines, two people with knowledge of the matter said, its first sanction against "pay-for-delay" deals. Following an inquiry launched in 2009, the European Union's anti-trust regulator will...
  • US: Ranbaxy shares down on $ 500 mn fine 14-05-2013 10:13 AM

    Mumbai: Ranbaxy Laboratories Ltd shares were down over 1 per cent in early trade on Tuesday after the generic drugmaker pleaded guilty to US felony charges related to drug safety and will pay $500 million in civil and criminal fines. The settlement is its largest-ever with a generic drugmaker over...
  • Ranbaxy fined $ 500 mn for selling adulterated drugs 14-05-2013 08:30 AM

    New Delhi: Generic drugmaker Ranbaxy has been fined $500 million by the US government after its subsidiary pleaded guilty to sale of adulterated drugs manufactured in India. It is the largest settlement by a generic medicine maker till date. It includes $150 million in payments for a criminal fine and...